Evoke Pharma Inc. (NASDAQ: EVOK)
$4.5600
+0.0600 ( +1.33% ) 11.2K
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
Market Data
Open
$4.5600
Previous close
$4.5000
Volume
11.2K
Market cap
$6.61M
Day range
$4.4050 - $4.6550
52 week range
$3.5400 - $17.4000
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
ars | Annual reports | 1 | Apr 10, 2024 |
def | Proxies and info statements | 19 | Apr 10, 2024 |
pre | Proxies and info statements | 18 | Mar 29, 2024 |
8-k | 8K-related | 12 | Mar 25, 2024 |
8-k | 8K-related | 11 | Mar 21, 2024 |
8-k | 8K-related | 11 | Mar 18, 2024 |
10-k | Annual reports | 63 | Mar 14, 2024 |
8-k | 8K-related | 14 | Mar 14, 2024 |
8-k | 8K-related | 1 | Feb 23, 2024 |
8-k | 8K-related | 2 | Feb 14, 2024 |